News
EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus–based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola ...
Our premium News+ ad-free experience – only $10 more every 4 weeks!
1d
KELOLAND.com on MSNMeasles inching closer to South DakotaMeasles is spreading, and since the initial outbreak in Texas, there are now more than 1,000 cases in the U.S this year.
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
10d
allAfrica.com on MSNUganda: In Uganda, Ebola Comes to an End, but Vigilance ContinuesPress Release - On April 26, 2025, Uganda's Minister of Health, Dr Jane Ruth Aceng Ocero, announced the end of Uganda's eighth Ebola outbreak.
A diagnostic test developed by Singaporean scientists to detect neutralising antibodies for multiple viruses is now in use in ...
The vaccine is designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above. It will be used to support preventive vaccination in countries most ...
The new vaccine – known during its development ... individuals aged 18 years and older at risk of infection from the Ebola virus. “This is an important step towards relieving the burden ...
MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...
Wu’s new bioinformatics tool addresses these limitations, expands the lens through which researchers can examine viral ...
and have few or no available treatments or vaccines. These pathogens include the viruses that cause Ebola and Lassa, as well as the reconstructed flu virus that caused the 1918 pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results